(Q42592170)

3 November 2017

Pure red cell aplasia associated with sulphasalazine (English)

1 reference

3 November 2017

A M Dunn

1

1 reference

PubMed ID

6118699

3 November 2017

G D Kerr

series ordinal

2

1 reference

PubMed ID

6118699

3 November 2017

language of work or name

English

0 references

publication date

1 December 1981

1 reference

3 November 2017

1 reference

3 November 2017

2

1 reference

3 November 2017

8258

1 reference

3 November 2017

1288

1 reference

Side Effects of Long-Term Treatment with Human Leukocyte Interferon

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2991523-3

7 January 2021

Tolerability of pure fibroblast interferon in man

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2991523-3

7 January 2021

Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2991523-3

7 January 2021

The prevalence of coronary heart disease and associated factors in an Australian rural community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2991523-3

7 January 2021

Hemolobin and the Risk of Cerebral Infarction: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2991523-3

7 January 2021

Relation between extent of coronary artery disease and blood viscosity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2991523-3

7 January 2021

10.1016/S0140-6736(81)91523-3

Identifiers

DOI

1 reference

3 November 2017

1 reference

PubMed ID

6118699